Derivation of contractile vascular smooth muscle cells from human pluripotent stem cells
This protocol describes a method to generate smooth muscle-like cells (SMLCs) from human embryonic stem cells and induced pluripotent stem (iPS) cells. The SMLCs are further cultured in low-serum medium for 18 days to generate contractile SMLCs (Con-SMLCs). Contractile cells mimic the native state of vascular smooth muscle cells (vSMCs) found in vessel walls. When SMLCs are cultured in high-serum medium in the presence of TGFb and PDFG-BB for 18 days, they differentiate into "synthetic" smooth muscle cells, termed Syn-SMLCs. Compared to Syn-SMLCs, Con-SMLCs have a reduced proliferation rate, increased contractile phenotype, numerous and active caveolae with enlarged endoplasmic reticulum and abundant stress fibers and bundles. When transplanted subcutaneously, Con-SMLCs encapsulated in Matrigel plugs migrated to newly grown vasculature, where they produced elastin to stabilize the blood vessels.
Read More
Summary for
Derivation of contractile vascular smooth muscle cells from human pluripotent stem cells